Clinical Trials Directory

Trials / Completed

CompletedNCT03703401

The Role of Hydrosalpinx in Recurrent Miscarriage

Status
Completed
Phase
Study type
Observational
Enrollment
137 (actual)
Sponsor
University of Birmingham · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Miscarriage affects one in five pregnancies and little progress has been made in understanding and treating this distressing condition. C. trachomatis is the most common sexually transmitted infection in the UK. C. trachomatis infection can have serious health consequences, including fallopian tube damage. Untreated C. trachomatis infection and tubal damage have been associated with miscarriage and adverse pregnancy outcomes such as preterm birth, low birth weight and stillbirth. A cohort study is needed to establish the prevalence of tubal disease in women with recurrent miscarriages. HyCoSy will be performed to identify tubal disease and establish the magnitude of the problem in the recurrent miscarriage population. The prognosis of tubal disease on miscarriage and other obstetric outcomes, and the role of medical interventions such as tubal surgery (to treat hydrosalpinx) on reducing miscarriage and adverse obstetric outcomes will also be studied. Objectives 1. Establish the prevalence of hydrosalpinx in the recurrent miscarriage population. 2. Establish the prognosis of women diagnosed with recurrent miscarriage with concurrent hydrosalpinx. 3. Explore the role of tubal surgery for improving reproductive outcomes in women with recurrent miscarriage population and hydrosalpinx.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHysterosalpingo-contrast-sonogramA contrast ultrasound scan to examine fallopian tube pathology and blockage

Timeline

Start date
2018-02-28
Primary completion
2020-09-11
Completion
2021-01-15
First posted
2018-10-12
Last updated
2022-11-16

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03703401. Inclusion in this directory is not an endorsement.